Repeat Dose Safety Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repeat Dose Safety Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repeat Dose Safety Study Today - Breaking & Trending Today

NEURELIS PRESENTS NOVEL, INVESTIGATIONAL ANALYSIS OF valtoco® (DIAZEPAM NASAL SPRAY) civ demonstrating increased time between seizure clusters AT THE 51st Child Neurology Society Annual Meeting

Published: October 13, 2022

/PRNewswire/ -- Neurelis, Inc., today announced findings from a novel, investigational analysis of the time between seizure clusters in pediatric patients...

Source: prnewswire.com

Related Topics:

United StatesAdrian RabinowiczBrittany BradrickPrnewswire Neurelis IncNeurelis IncChild Neurology Society Annual MeetingDrug AdministrationClinical DevelopmentLennox Gastaut SyndromeOver TimePediatric PatientsLong Term Open LabelRepeat Dose Safety StudyDiazepam Nasal SpraySeizure ClustersLennox Gastaut Syndrome Respond DifferentlyFinal SafetyEffectiveness Results FromNeurelis Orphan Drug ExclusivitySafety InformationNervous SystemSerious Adverse ReactionsBenzyl AlcoholPrescribing InformationBoxed Warning

NEURELIS PRESENTS NOVEL, INVESTIGATIONAL ANALYSIS OF valtoco® (DIAZEPAM NASAL SPRAY) civ demonstrating increased time between seizure clusters AT THE 51st Child Neurology Society Annual Meeting

Published: October 13, 2022

/PRNewswire/ -- Neurelis, Inc., today announced findings from a novel, investigational analysis of the time between seizure clusters in pediatric patients...

Source: prnewswire.com

Related Topics:

United StatesAdrian RabinowiczBrittany BradrickPrnewswire Neurelis IncNeurelis IncChild Neurology Society Annual MeetingDrug AdministrationClinical DevelopmentLennox Gastaut SyndromeOver TimePediatric PatientsLong Term Open LabelRepeat Dose Safety StudyDiazepam Nasal SpraySeizure ClustersLennox Gastaut Syndrome Respond DifferentlyFinal SafetyEffectiveness Results FromNeurelis Orphan Drug ExclusivitySafety InformationNervous SystemSerious Adverse ReactionsBenzyl AlcoholPrescribing InformationBoxed Warning